7FAY

Crystal structure of SARS-CoV-2 main protease in complex with (R)-1a

7FAY の概要

• エントリーDOI: 10.2210/pdb7fay/pdb
• 分子名称: 3C-like proteinase, (2~{R})-~{N}-[(1~{R})-2-(~{tert}-butylamino)-2-oxidanylidene-1-pyridin-3-yl-ethyl]-~{N}-(4-~{tert}-butylphenyl)-2-oxidanyl-propanamide (3 entities in total)
• 機能のキーワード: coronavirus, protease, inhibitor, complex, viral protein., viral protein
• 由来する生物種: Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 34237.08

構造登録者

Zeng, R.,Quan, B.X.,Liu, X.L.,Lei, J. (登録日: 2021-07-08, 公開日: 2021-07-21, 最終更新日: 2023-11-29)

• 主引用文献: Quan, B.X.,Shuai, H.,Xia, A.J.,Hou, Y.,Zeng, R.,Liu, X.L.,Lin, G.F.,Qiao, J.X.,Li, W.P.,Wang, F.L.,Wang, K.,Zhou, R.J.,Yuen, T.T.,Chen, M.X.,Yoon, C.,Wu, M.,Zhang, S.Y.,Huang, C.,Wang, Y.F.,Yang, W.,Tian, C.,Li, W.M.,Wei, Y.Q.,Yuen, K.Y.,Chan, J.F.,Lei, J.,Chu, H.,Yang, S.; An orally available M pro inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron.; Nat Microbiol, 7:716-725, 2022; PubMed: 35477751; DOI: 10.1038/s41564-022-01119-7

実験手法

X-RAY DIFFRACTION (2.1 Å)